SCHEMBL634752

SCHEMBL634752

Cc1cc(N2C(=O)N(CCCCCN3C(=O)N(c4ccc(NC(=O)O)c(C)c4)C(=O)C3(C)C)C(C)(C)C2=O)ccc1NC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
AR P10275 7/20 0.46
PGR P06401 1/20 0.46
PPARG P37231 1/20 0.39
PPARD Q03181 1/20 0.39
PPARA Q07869 1/20 0.39
HDAC1 Q13547 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL634405 0.80 AR (0.45) ARPGRPPARGPPARDPPARA
SCHEMBL634753 0.79 PPARG (0.39) PPARGPPARDPPARA
SCHEMBL633694 0.77 AR (0.59) ARPGRHDAC1
SCHEMBL633631 0.75 SMN1; SMN2 (0.49) ARPGR
SCHEMBL629334 0.74 AR (0.38) ARPGRPPARGPPARDPPARA
SCHEMBL628964 0.73 AR (0.37) ARPGRHDAC1
SCHEMBL629437 0.73 AR (0.37) ARPGRPPARGPPARDPPARA
SCHEMBL631033 0.72 AR (0.37) ARPGRPPARGPPARDPPARA
SCHEMBL14735643 0.71 AR (0.40) ARPGR
SCHEMBL629028 0.71 SMN1; SMN2 (0.45) ARPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2419422-B1 IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AND USE THEREOF AS A MEDICAMENT IPSEN PHARMA SAS (FR) 2014-10-15 EP disclosed
US-8624037-B2 Imidazolidine-2,4-dione derivatives and use thereof as a medicament IPSEN PHARMA S.A.S. (FR) 2014-01-07 US disclosed
EP-2419422-A1 IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AND USE THEREOF AS A MEDICAMENT IPSEN PHARMA S.A.S. (FR) 2012-02-22 EP disclosed
WO-2010119194-A1 IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AND USE THEREOF AS A MEDICAMENT IPSEN PHARMA S.A.S. (FR) 2010-10-21 WO disclosed